نتایج جستجو برای: fgfr

تعداد نتایج: 1529  

Journal: :Development 2009
Hunki Paek Grigoriy Gutin Jean M Hébert

The FGF family of extracellular signaling factors has been proposed to play multiple roles in patterning the telencephalon, the precursor to the cerebrum. In this study, unlike previous ones, we effectively abolish FGF signaling in the anterior neural plate via deletion of three FGF receptor (FGFR) genes. Triple FGFR mutant mice exhibit a complete loss of the telencephalon, except the dorsal mi...

2012
Vashti Galpin

Src: An oncoprotein, implicated in tumour formation and motility of cells; specifically, a non-receptor tyrosine kinase (Src, aSrc). FGF: A growth factor that is involved in signalling between cells. FGF receptor: A protein that sit across the membrane of the cell and to which FGF can bind. It transfers signals outside the cell to signalling pathways within the cell (FGFR). FGFR complex: A comp...

Journal: :Journal of medicinal chemistry 2000
A M Thompson C J Connolly J M Hamby S Boushelle B G Hartl A M Amar A J Kraker D L Driscoll R W Steinkampf S J Patmore P W Vincent B J Roberts W L Elliott W Klohs W R Leopold H D Showalter W A Denny

A series of 3-aryl-1,6-naphthyridine-2,7-diamines and related 2-ureas were prepared and evaluated as inhibitors of the FGF receptor-1 tyrosine kinase. Condensation of 4,6-diaminonicotinaldehyde and substituted phenylacetonitriles gave intermediate naphthyridine-2,7-diamines, and direct reaction of the monoanion of these (NaH/DMF) with alkyl or aryl isocyanates selectively gave the 2-ureas in va...

2012
Joseph M. Gozgit Matthew J. Wong Lauren Moran Scott Wardwell Qurish K. Mohemmad Narayana I. Narasimhan William C. Shakespeare Frank Wang Tim Clackson Victor M. Rivera

Members of the fibroblast growth factor receptor family of kinases (FGFR1–4) are dysregulated in multiple cancers. Ponatinib (AP24534) is an oral multitargeted tyrosine kinase inhibitor being explored in a pivotal phase II trial in patients with chronic myelogenous leukemia due to its potent activity against BCR-ABL. Ponatinib has also been shown to inhibit the in vitro kinase activity of all f...

Journal: :Clinical Cancer Research 2015

Journal: :Reactome - a curated knowledgebase of biological pathways 2016

Journal: :Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2012

Journal: :Cancer Treatment Reviews 2021

Cholangiocarcinomas (CCAs) are rare but aggressive tumours of the bile ducts, which often diagnosed at an advanced stage and have poor outcomes on systemic therapy. Somatic alterations with therapeutic implications been identified in almost half CCAs, particular intrahepatic CCA (iCCA), subtype arising from ducts within liver. Among patients CCA, fibroblast growth factor receptor 2 (FGFR2) fusi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید